Diazoxide
-
Diazoxide
structure -
-
CAS No:
364-98-7
-
Formula:
C8H7ClN2O2S
-
Chemical Name:
Diazoxide
-
Synonyms:
2H-1,2,4-Benzothiadiazine,7-chloro-3-methyl-,1,1-dioxide;4H-1,2,4-Benzothiadiazine,7-chloro-3-methyl-,1,1-dioxide;SRG 95213;7-Chloro-3-methyl-2H-1,2,4-benzothiadiazine 1,1-dioxide;Diazoxide;Dizoxide;Hyperstat;3-Methyl-7-chloro-1,2,4-benzothiadiazine 1,1-dioxide;Proglicem;Mutabase;NSC 64198;Eudemine injection;Sch 6783;Hypertonalum;Proglycem;NSC 76130;1342899-70-0
-
Categories:
Active Pharmaceutical Ingredients > Circulatory System Drugs
-
CAS No:
Description
Diazoxide is an ATP-sensitive potassium channel activator ; can be used to treat hyperinsulinism.
Solid
Diazoxide is a benzothiadiazine that is the S,S-dioxide of 2H-1,2,4-benzothiadiazine which is substituted at position 3 by a methyl group and at position 7 by chlorine. A peripheral vasodilator, it increases the concentration of glucose in the plasma and inhibits the secretion of insulin by the beta- cells of the pancreas. It is used orally in the management of intractable hypoglycaemia and intravenously in the management of hypertensive emergencies. It has a role as an antihypertensive agent, a sodium channel blocker, a vasodilator agent, a K-ATP channel agonist, a beta-adrenergic agonist, a cardiotonic drug, a bronchodilator agent, a sympathomimetic agent and a diuretic. It is a benzothiadiazine, a sulfone and an organochlorine compound.|A benzothiadiazine derivative that is a peripheral vasodilator used for hypertensive emergencies. It lacks diuretic effect, apparently because it lacks a sulfonamide group.|Diazoxide is a benzothiadiazine derivate with antihypertensive and hyperglycemic activities. Diazoxide increases membrane permeability to potassium ions in vascular smooth muscle, thereby stabilizing the membrane action potential and preventing vascular smooth muscle contraction; this results in peripheral vasodilatation and decreases in peripheral vascular resistance. This agent also inhibits insulin release by interacting with ATP-sensitive potassium channels of pancreatic islet beta-cells.
Diazoxide Basic Attributes
230.67
230.67
206-668-1
O5CB12L4FN
759574|76130|64198
DTXSID7022914
C428
C - Cardiovascular system|V - Various
2933990090
Characteristics
66.9
1.2
Solid
1.6±0.1 g/cm3
330.5 °C
414.8°C at 760 mmHg
204.6±29.3 °C
1.692
soluble in 0.1M NaOH. Insoluble in water or in methanol.
Store at RT
8.74None
8.74
143.7 Ų [M+H]+ [CCS Type: TW, Method: calibrated with polyalanine and drug standards]
Safety Information
NONH for all modes of transport
3
22-36/37/38
22-26-36
DK8185000
Xn
P261-P305 + P351 + P338
H302-H315-H319-H335
|Danger|H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]|P201, P202, P260, P261, P264, P270, P271, P280, P281, P301+P312, P302+P352, P304+P340, P305+P351+P338, P308+P313, P312, P314, P321, P330, P332+P313, P337+P313, P362, P403+P233, P405, and P501|Aggregated GHS information provided by 88 companies from 7 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Toxicity
Oral LD50 in rat and mouse: 980 mg/kg and 444 mg/kg, respectively.
Very high (more than 90%) to serum proteins.
Drug Information
Used parentally to treat hypertensive emergencies. Also used to treat hypoglycemia secondary to insulinoma.
Diazoxide is a potassium channel activator. Its mechanism of action revolves around enhancing cell membrane permeability to potassium ions. This action consequently elicits the relaxation of local smooth muscles. This switches off voltage-gated calcium ion channels which inhibits the generation of an action potential.
Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)|Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)
Readily absorbed following oral administration.|Proglycem is extensively bound (more than 90%) to serum proteins, and is excreted in the kidneys.
Hepatic.
28 ±8.3 hours in normal adults.
Diazoxide inhibits insulin release from the pancreas, by opening potassium channels in the beta cell membrane. Diazoxide is chemically related to thiazide diuretics but does not inhibit carbonic anhydrase and does not have chloriuretic or natriuretic activity. It also exhibits hypotensive activity by reducing arteriolar smooth muscle and vascular resistance.
Diazoxide
Diazoxide Use and Manufacturing
Preparation of diazine crude.Take 5-chloro-2-aminobenzenesulfonamide (III) 100g, potassium carbonate 100g, chloroform 600g, Followed by 1L round bottom three-necked flask, Acetyl chloride 80g was added dropwise with stirring at 0 to 10 ° C, Add at room temperature for 6 hours. After the reaction is completed, The reaction solution was poured into 800g of ice water, Slow stirring, Standing, Divided chloroform layer, Concentrate to dryness under reduced pressure.To the resulting oil was added diphenyl ether 400g, The reaction was stirred at 250 ~ 250 for 1 hour, Cool to room temperature, Solid was isolated, washed with ethanol, dry, A pale yellow diazine crude was obtained.(C) Preparation of diazoxide (I).The resulting diazine crude product was recrystallized from 80percent ethanol, Product dry, Smash, Obtained white crystalline powder (sample 3), Diazoxide (I) 85.5 g.The total molar yield is 74.3percent as 5-chloro-2-nitrobenzenesulfonamide.
Diazoxide reduces status epilepticus neuron damage in diabetes.
Human Drugs -> FDA Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book) -> Active Ingredients|Pharmaceuticals
Computed Properties
Molecular Weight:230.67
XLogP3:1.2
Hydrogen Bond Donor Count:1
Hydrogen Bond Acceptor Count:3
Exact Mass:229.9916763
Monoisotopic Mass:229.9916763
Topological Polar Surface Area:66.9
Heavy Atom Count:14
Complexity:360
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes
Drug Function and Efficacy
It can relax the smooth muscle of arterioles, dilate blood vessels, reduce peripheral resistance, lower blood pressure, and counteract the vasoconstriction effect of various substances. It can reflexively increase heart rate and cardiac output, while the blood flow of the brain, kidneys, and coronary arteries remains unchanged. It can cause an increase in plasma renin activity, affecting the antihypertensive effect. It can inhibit the secretion of insulin by pancreatic beta cells and increase blood sugar concentration.
Registered Holders
-
GUANG'AN KINGDAY PHARMA AND CHEM CO LTD
Active
United States
-
NOVITIUM PHARMA LLC
Active
United States
-
BIOPHORE INDIA PHARMACEUTICALS PVT LTD
Active
United States
Recommended Suppliers of Diazoxide
-
CN
5 YRS
Business licensedTrader Supplier of Intermediates,Building blocks,API,Silicones,Peptides,Lab chemicals,Biochemicals,Pharmaceuticals,Screening Compounds,Food Additives
Learn More Other Chemicals
-
Dronedarone
141626-36-0
-
Zofenopril calcium
81938-43-4
-
3-Bromo-1,3,4,5-tetrahydro-2H-1-benzazepin-2-one
86499-96-9
-
Tirofiban hydrochloride monohydrate Formula
150915-40-5
-
Saxagliptin Formula
361442-04-8
-
Dapoxetine Formula
119356-77-3
-
Fasudil Structure
103745-39-7
-
3,5-Pyridinedicarboxylic acid, 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-, 3-methyl 5-[(1-oxobutoxy)methyl] ester Structure
167221-71-8
-
What is 3-[(2R,5S)-5-(4-Fluorophenyl)-2-[(S)-[(4-fluorophenyl(amino)]][4-[trimethylsilyl]-oxy]phenyl]methyl]-1-oxo-5-[(trimethylsily)-oxy]pentyl]-4-phenyl-(4S)-2-oxazolidinone
272778-12-8
-
What is (-)-Oxyfedrine
15687-41-9